Clinical Trial

Evaluating an AI Tool for Detecting Thyrotoxic States

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 1, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This observational study aims to evaluate the performance of a software-based medical device, Glandy HYPER, in detecting the thyrotoxic state in patients with hyperthyroidism. The device utilizes heart rate data collected from commercially available wearable devices and compares it with thyroid function test results. The study will enroll patients diagnosed with Graves' disease, monitoring their heart rate during sleep and correlating these measurements with free T4 levels obtained through serial blood testing. No investigational device output will be disclosed to participants, and the study will not alter standard clinical care.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-04.
Status change: Not Yet Recruiting → Recruiting 2026-05-28
Trial Details
NCT Number NCT07017907
Lead Sponsor THYROSCOPE INC.
Conditions Graves Disease, Hyperthyroidism/Thyrotoxicosis
Enrollment 15 participants
Start Date 2026-01-09
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-01